Dabigatran etexilate found superior to warfarin in study
The trial used a previously developed method to integrate ischemic and bleeding events as "ischemic stroke equivalents" to compare weighted benefit of two doses of dabigatran with each
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.